Dejar de fumar en el trastorno mental grave: desafíos y oportunidades en tiempos de la COVID-1
DOI:
https://doi.org/10.20882/adicciones.1579Palabras clave:
COVID-19, Enfermedad del coronavirus, Dejar de fumar, Enfermedad mental severa.Resumen
Carta al editor.Citas
Balanzá-Martínez, V., Atienza-Carbonell, B., Kapczinski, F. y De Boni, R. B. (2020). Lifestyle behaviours during the COVID-19 - time to connect. Acta Psychiatrica Scandinavica, 141, 399-400. doi:org/10.1111/acps.13177.
De Hert, M., Correll, C. U., Bobes, J., Cetkovich-Bakmas, M., Cohen, D., Asai, I., … Leucht, S. (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry, 10, 52-77. doi:10.1002/j.2051-5545.2011.tb00014.x.
García-Álvarez, L., de la Fuente-Tomás, L., Sáiz, P. A., García-Portilla, M. P. y Bobes, J. (2020). Will changes in alcohol and tobacco use be seen during the covid-19 lockdown?. Adicciones, 32, 85-89. doi:10.20882/adicciones.1546.
Prochaska, J. J., Reyes, R. S., Schroeder, S. A., Daniels, A. S., Doederlein, A. y Bergeson, B. (2011). An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder. Bipolar Disorders, 13, 466-473. doi:10.1111/j.1399-5618.2011.00944.x.
Rüther, T., Bobes, J., De Hert, M., Svensson, T. H., Mann, K., Batra, A., … Möller, H. J. (2014). EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. European Psychiatry, 29, 65-82. doi:10.1016/j.eurpsy.2013.11.002.
Sarramea, F., Jaen-Moreno, M. J., Balanzá-Martínez, V., Osuna, M. I., Alcalá, J. Á., Montiel, F. J., … Gutiérrez-Rojas, L. (2019a). Setting the stage to quit smoking in bipolar disorder patients: Brief advice in clinical practice. Adicciones, 31, 136-145. doi:10.20882/adicciones.1006.
Sarramea Crespo, F., Jaén-Moreno, M. J., Gutiérrez-Rojas, L., Balanzá-Martínez, V., García-Alvarez, L., Saiz Martínez, P. A., … Bobes, J. (2019b). “Readiness to Change” predicts efficacy of reduction among smokers with severe mental illness. European Addiction Research, 25, 256-262. doi:10.1159/000500450.
Sarramea, F., Jaén-Moreno, M. J., Feu, N., Redondo-Écija, J., Balanzá-Martínez, V., Gutiérrez-Rojas, L. y García-Portilla, M. P. (2019c). Preparar la cesación tabáquica en el trastorno mental grave: Diagnóstico precoz y oportunidades de prevención. Revista de Psiquiatría y Salud Mental, 12, 133-134. doi:10.1016/j.rpsm.2018.08.001.
Vardavas, C. y Nikitara, K. (2020). COVID-19 and smoking: A systematic review of the evidence. Tobaco Induced Diseases, 18, 1-4. doi:10.18332/tid/119324.
Wang, B., Ruobao, L., Zhong, L. y Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis. Aging, 12, 6049-6057. doi:10.18632/AGING.103000.
Yi, Y., Lagniton, P. N. P., Ye, S., Li, E. y Xu, R. H. (2020). COVID-19: What has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences, 16, 1753-1766. doi:10.7150/ijbs.45134.
